Found: 15
Select item for more details and to access through your institution.
Clinical and pathological features of primary renal synovial sarcoma: analysis of 64 cases from 11 years of medical literature.
- Published in:
- BJU International, 2012, v. 110, n. 10, p. 1449, doi. 10.1111/j.1464-410X.2012.11105.x
- By:
- Publication type:
- Article
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/7317964
- By:
- Publication type:
- Article
Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 10, p. 2569, doi. 10.3390/ijms20102569
- By:
- Publication type:
- Article
Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 840, doi. 10.3390/cancers13040840
- By:
- Publication type:
- Article
Plasma Androgen Receptor in Prostate Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1719, doi. 10.3390/cancers11111719
- By:
- Publication type:
- Article
Combining liquid biopsy and functional imaging analysis in metastatic castration‐resistant prostate cancer helps predict treatment outcome.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 2, p. 538, doi. 10.1002/1878-0261.13120
- By:
- Publication type:
- Article
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.716467
- By:
- Publication type:
- Article
Post-docetaxel therapy in castration resistant prostate cancer – the forest is growing in the desert.
- Published in:
- Therapeutic Advances in Urology, 2012, v. 4, n. 3, p. 107, doi. 10.1177/1756287212440302
- By:
- Publication type:
- Article
Testosterone levels and androgen receptor copy number variations in castration‐resistant prostate cancer treated with abiraterone or enzalutamide.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1211, doi. 10.1002/pros.23804
- By:
- Publication type:
- Article
Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support.
- Published in:
- Frontiers in Endocrinology, 2019, p. N.PAG, doi. 10.3389/fendo.2019.00318
- By:
- Publication type:
- Article
Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules.
- Published in:
- Oncology, 2012, v. 84, n. 2, p. 92, doi. 10.1159/000343821
- By:
- Publication type:
- Article
Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical Practice.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.859510
- By:
- Publication type:
- Article
Plasma AR Copy Number Changes and Outcome to Abiraterone and Enzalutamide.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.567809
- By:
- Publication type:
- Article
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.565857
- By:
- Publication type:
- Article
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01325
- By:
- Publication type:
- Article